A.R.T. Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-12,825
| Closed | -$11K | – | 181 |
|
2020
Q2 | $11K | Buy |
+12,825
| New | +$11K | 0.02% | 271 |
|
2020
Q1 | – | Sell |
-32,225
| Closed | -$29K | – | 561 |
|
2019
Q4 | $29K | Buy |
32,225
+19,594
| +155% | +$17.6K | ﹤0.01% | 1272 |
|
2019
Q3 | $12K | Sell |
12,631
-17,100
| -58% | -$16.2K | ﹤0.01% | 1383 |
|
2019
Q2 | $33K | Buy |
+29,731
| New | +$33K | ﹤0.01% | 1274 |
|
2019
Q1 | – | Sell |
-53,313
| Closed | -$49K | – | 1464 |
|
2018
Q4 | $49K | Buy |
+53,313
| New | +$49K | ﹤0.01% | 1218 |
|
2018
Q3 | – | Sell |
-13,294
| Closed | -$23K | – | 1553 |
|
2018
Q2 | $23K | Sell |
13,294
-87,331
| -87% | -$151K | ﹤0.01% | 1359 |
|
2018
Q1 | $236K | Sell |
100,625
-13,819
| -12% | -$32.4K | 0.01% | 1217 |
|
2017
Q4 | $215K | Buy |
114,444
+85,476
| +295% | +$161K | 0.01% | 1138 |
|
2017
Q3 | $71K | Sell |
28,968
-7,247
| -20% | -$17.8K | ﹤0.01% | 1233 |
|
2017
Q2 | $99K | Buy |
+36,215
| New | +$99K | 0.01% | 1255 |
|